Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) was the target of a large increase in short interest in September. As of September 30th, there was short interest totalling 548,700 shares, an increase of 36.5% from the September 15th total of 401,900 shares. Based on an average trading volume of 131,900 shares, the short-interest ratio is currently 4.2 days.
In other news, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the business's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the transaction, the director now directly owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,917 shares of company stock worth $3,050,082. Corporate insiders own 4.60% of the company's stock.
A number of institutional investors and hedge funds have recently modified their holdings of ADUS. Ellsworth Advisors LLC acquired a new position in Addus HomeCare during the second quarter valued at approximately $598,000. Quadrature Capital Ltd acquired a new position in Addus HomeCare during the first quarter valued at approximately $1,557,000. Lord Abbett & CO. LLC acquired a new position in Addus HomeCare during the first quarter valued at approximately $8,274,000. Vanguard Group Inc. grew its holdings in Addus HomeCare by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company's stock valued at $116,753,000 after purchasing an additional 38,876 shares during the period. Finally, SG Americas Securities LLC acquired a new position in Addus HomeCare during the second quarter valued at approximately $842,000. 95.35% of the stock is owned by institutional investors.
ADUS opened at $130.63 on Friday. The company has a market cap of $2.36 billion, a price-to-earnings ratio of 32.41, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. The firm has a 50 day simple moving average of $129.54 and a 200 day simple moving average of $117.24. Addus HomeCare has a fifty-two week low of $78.35 and a fifty-two week high of $136.12.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts' consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. Addus HomeCare's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.94 earnings per share. As a group, analysts expect that Addus HomeCare will post 4.58 EPS for the current year.
A number of research firms have commented on ADUS. Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an "outperform" rating in a research report on Monday, September 23rd. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday. They issued an "overweight" rating and a $150.00 price target on the stock. Royal Bank of Canada restated an "outperform" rating and issued a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday, September 3rd. TD Cowen boosted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a "buy" rating in a research note on Thursday, August 8th. Finally, Stephens reaffirmed an "overweight" rating and issued a $138.00 target price on shares of Addus HomeCare in a research note on Tuesday, August 6th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of "Moderate Buy" and an average price target of $131.38.
View Our Latest Report on ADUS
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.